US 10836759
Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer
granted A61KA61K31/496A61K31/4995
Quick answer
US patent 10836759 (Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/496, A61K31/4995, A61P, A61P35/00